Dolutegravir intermediates are important chemical building blocks in the synthesis of Dolutegravir and are mainly used in the development and production of anti-HIV drugs. As an HIV integrase inhibitor, the synthesis of Dolutegravir requires a variety of intermediates, which play a key role in forming the core structure of the drug and improving the stability and biological activity of the drug.
The global Dolutegravir Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Dolutegravir Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dolutegravir Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dolutegravir Intermediates include Ginkgo Bioworks, Zymergen, Codexis, Amyris, Novozymes, Gilead Sciences, Merck, Amgen, Enal Drugs, Abiochem Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dolutegravir Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir Intermediates.
The Dolutegravir Intermediates market size, estimations, and forecasts are provided in terms of output/shipments (Kilotons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dolutegravir Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ginkgo Bioworks
Zymergen
Codexis
Amyris
Novozymes
Gilead Sciences
Merck
Amgen
Enal Drugs
Abiochem Biotechnology
Sineva Pharmaceutical
Bepharm Science&Technology
Weijia Pharma
Bionna Medicine
Mesochem Technology
SynFarm Pharmaceutical
Abydos Pharma
Dingxintong Pharmaceutical
by Type
Difluorobenzoic Acid Derivatives
Oxetane Derivatives
Others
by Application
Original Drug
Generic Drug
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dolutegravir Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dolutegravir Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dolutegravir Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Dolutegravir Intermediates Market Overview
1.1 Product Definition
1.2 Dolutegravir Intermediates by Type
1.2.1 Global Dolutegravir Intermediates Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Difluorobenzoic Acid Derivatives
1.2.3 Oxetane Derivatives
1.2.4 Others
1.3 Dolutegravir Intermediates by Application
1.3.1 Global Dolutegravir Intermediates Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Global Market Growth Prospects
1.4.1 Global Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dolutegravir Intermediates Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dolutegravir Intermediates Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dolutegravir Intermediates Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dolutegravir Intermediates Production Market Share by Manufacturers (2019-2024)
2.2 Global Dolutegravir Intermediates Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dolutegravir Intermediates, Industry Ranking, 2022 VS 2023
2.4 Global Dolutegravir Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Dolutegravir Intermediates Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dolutegravir Intermediates, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dolutegravir Intermediates, Product Offered and Application
2.8 Global Key Manufacturers of Dolutegravir Intermediates, Date of Enter into This Industry
2.9 Dolutegravir Intermediates Market Competitive Situation and Trends
2.9.1 Dolutegravir Intermediates Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dolutegravir Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dolutegravir Intermediates Production by Region
3.1 Global Dolutegravir Intermediates Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dolutegravir Intermediates Production Value by Region (2019-2030)
3.2.1 Global Dolutegravir Intermediates Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dolutegravir Intermediates by Region (2025-2030)
3.3 Global Dolutegravir Intermediates Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dolutegravir Intermediates Production by Region (2019-2030)
3.4.1 Global Dolutegravir Intermediates Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dolutegravir Intermediates by Region (2025-2030)
3.5 Global Dolutegravir Intermediates Market Price Analysis by Region (2019-2024)
3.6 Global Dolutegravir Intermediates Production and Value, Year-over-Year Growth
3.6.1 North America Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
4 Dolutegravir Intermediates Consumption by Region
4.1 Global Dolutegravir Intermediates Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dolutegravir Intermediates Consumption by Region (2019-2030)
4.2.1 Global Dolutegravir Intermediates Consumption by Region (2019-2030)
4.2.2 Global Dolutegravir Intermediates Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dolutegravir Intermediates Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dolutegravir Intermediates Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dolutegravir Intermediates Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dolutegravir Intermediates Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Dolutegravir Intermediates Production by Type (2019-2030)
5.1.1 Global Dolutegravir Intermediates Production by Type (2019-2024)
5.1.2 Global Dolutegravir Intermediates Production by Type (2025-2030)
5.1.3 Global Dolutegravir Intermediates Production Market Share by Type (2019-2030)
5.2 Global Dolutegravir Intermediates Production Value by Type (2019-2030)
5.2.1 Global Dolutegravir Intermediates Production Value by Type (2019-2024)
5.2.2 Global Dolutegravir Intermediates Production Value by Type (2025-2030)
5.2.3 Global Dolutegravir Intermediates Production Value Market Share by Type (2019-2030)
5.3 Global Dolutegravir Intermediates Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dolutegravir Intermediates Production by Application (2019-2030)
6.1.1 Global Dolutegravir Intermediates Production by Application (2019-2024)
6.1.2 Global Dolutegravir Intermediates Production by Application (2025-2030)
6.1.3 Global Dolutegravir Intermediates Production Market Share by Application (2019-2030)
6.2 Global Dolutegravir Intermediates Production Value by Application (2019-2030)
6.2.1 Global Dolutegravir Intermediates Production Value by Application (2019-2024)
6.2.2 Global Dolutegravir Intermediates Production Value by Application (2025-2030)
6.2.3 Global Dolutegravir Intermediates Production Value Market Share by Application (2019-2030)
6.3 Global Dolutegravir Intermediates Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Ginkgo Bioworks
7.1.1 Ginkgo Bioworks Dolutegravir Intermediates Company Information
7.1.2 Ginkgo Bioworks Dolutegravir Intermediates Product Portfolio
7.1.3 Ginkgo Bioworks Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Ginkgo Bioworks Main Business and Markets Served
7.1.5 Ginkgo Bioworks Recent Developments/Updates
7.2 Zymergen
7.2.1 Zymergen Dolutegravir Intermediates Company Information
7.2.2 Zymergen Dolutegravir Intermediates Product Portfolio
7.2.3 Zymergen Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Zymergen Main Business and Markets Served
7.2.5 Zymergen Recent Developments/Updates
7.3 Codexis
7.3.1 Codexis Dolutegravir Intermediates Company Information
7.3.2 Codexis Dolutegravir Intermediates Product Portfolio
7.3.3 Codexis Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Codexis Main Business and Markets Served
7.3.5 Codexis Recent Developments/Updates
7.4 Amyris
7.4.1 Amyris Dolutegravir Intermediates Company Information
7.4.2 Amyris Dolutegravir Intermediates Product Portfolio
7.4.3 Amyris Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Amyris Main Business and Markets Served
7.4.5 Amyris Recent Developments/Updates
7.5 Novozymes
7.5.1 Novozymes Dolutegravir Intermediates Company Information
7.5.2 Novozymes Dolutegravir Intermediates Product Portfolio
7.5.3 Novozymes Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Novozymes Main Business and Markets Served
7.5.5 Novozymes Recent Developments/Updates
7.6 Gilead Sciences
7.6.1 Gilead Sciences Dolutegravir Intermediates Company Information
7.6.2 Gilead Sciences Dolutegravir Intermediates Product Portfolio
7.6.3 Gilead Sciences Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Gilead Sciences Main Business and Markets Served
7.6.5 Gilead Sciences Recent Developments/Updates
7.7 Merck
7.7.1 Merck Dolutegravir Intermediates Company Information
7.7.2 Merck Dolutegravir Intermediates Product Portfolio
7.7.3 Merck Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Merck Main Business and Markets Served
7.7.5 Merck Recent Developments/Updates
7.8 Amgen
7.8.1 Amgen Dolutegravir Intermediates Company Information
7.8.2 Amgen Dolutegravir Intermediates Product Portfolio
7.8.3 Amgen Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Amgen Main Business and Markets Served
7.8.5 Amgen Recent Developments/Updates
7.9 Enal Drugs
7.9.1 Enal Drugs Dolutegravir Intermediates Company Information
7.9.2 Enal Drugs Dolutegravir Intermediates Product Portfolio
7.9.3 Enal Drugs Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Enal Drugs Main Business and Markets Served
7.9.5 Enal Drugs Recent Developments/Updates
7.10 Abiochem Biotechnology
7.10.1 Abiochem Biotechnology Dolutegravir Intermediates Company Information
7.10.2 Abiochem Biotechnology Dolutegravir Intermediates Product Portfolio
7.10.3 Abiochem Biotechnology Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Abiochem Biotechnology Main Business and Markets Served
7.10.5 Abiochem Biotechnology Recent Developments/Updates
7.11 Sineva Pharmaceutical
7.11.1 Sineva Pharmaceutical Dolutegravir Intermediates Company Information
7.11.2 Sineva Pharmaceutical Dolutegravir Intermediates Product Portfolio
7.11.3 Sineva Pharmaceutical Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Sineva Pharmaceutical Main Business and Markets Served
7.11.5 Sineva Pharmaceutical Recent Developments/Updates
7.12 Bepharm Science&Technology
7.12.1 Bepharm Science&Technology Dolutegravir Intermediates Company Information
7.12.2 Bepharm Science&Technology Dolutegravir Intermediates Product Portfolio
7.12.3 Bepharm Science&Technology Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Bepharm Science&Technology Main Business and Markets Served
7.12.5 Bepharm Science&Technology Recent Developments/Updates
7.13 Weijia Pharma
7.13.1 Weijia Pharma Dolutegravir Intermediates Company Information
7.13.2 Weijia Pharma Dolutegravir Intermediates Product Portfolio
7.13.3 Weijia Pharma Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Weijia Pharma Main Business and Markets Served
7.13.5 Weijia Pharma Recent Developments/Updates
7.14 Bionna Medicine
7.14.1 Bionna Medicine Dolutegravir Intermediates Company Information
7.14.2 Bionna Medicine Dolutegravir Intermediates Product Portfolio
7.14.3 Bionna Medicine Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Bionna Medicine Main Business and Markets Served
7.14.5 Bionna Medicine Recent Developments/Updates
7.15 Mesochem Technology
7.15.1 Mesochem Technology Dolutegravir Intermediates Company Information
7.15.2 Mesochem Technology Dolutegravir Intermediates Product Portfolio
7.15.3 Mesochem Technology Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Mesochem Technology Main Business and Markets Served
7.15.5 Mesochem Technology Recent Developments/Updates
7.16 SynFarm Pharmaceutical
7.16.1 SynFarm Pharmaceutical Dolutegravir Intermediates Company Information
7.16.2 SynFarm Pharmaceutical Dolutegravir Intermediates Product Portfolio
7.16.3 SynFarm Pharmaceutical Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.16.4 SynFarm Pharmaceutical Main Business and Markets Served
7.16.5 SynFarm Pharmaceutical Recent Developments/Updates
7.17 Abydos Pharma
7.17.1 Abydos Pharma Dolutegravir Intermediates Company Information
7.17.2 Abydos Pharma Dolutegravir Intermediates Product Portfolio
7.17.3 Abydos Pharma Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Abydos Pharma Main Business and Markets Served
7.17.5 Abydos Pharma Recent Developments/Updates
7.18 Dingxintong Pharmaceutical
7.18.1 Dingxintong Pharmaceutical Dolutegravir Intermediates Company Information
7.18.2 Dingxintong Pharmaceutical Dolutegravir Intermediates Product Portfolio
7.18.3 Dingxintong Pharmaceutical Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Dingxintong Pharmaceutical Main Business and Markets Served
7.18.5 Dingxintong Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dolutegravir Intermediates Industry Chain Analysis
8.2 Dolutegravir Intermediates Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dolutegravir Intermediates Production Mode & Process
8.4 Dolutegravir Intermediates Sales and Marketing
8.4.1 Dolutegravir Intermediates Sales Channels
8.4.2 Dolutegravir Intermediates Distributors
8.5 Dolutegravir Intermediates Customers
9 Dolutegravir Intermediates Market Dynamics
9.1 Dolutegravir Intermediates Industry Trends
9.2 Dolutegravir Intermediates Market Drivers
9.3 Dolutegravir Intermediates Market Challenges
9.4 Dolutegravir Intermediates Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Ginkgo Bioworks
Zymergen
Codexis
Amyris
Novozymes
Gilead Sciences
Merck
Amgen
Enal Drugs
Abiochem Biotechnology
Sineva Pharmaceutical
Bepharm Science&Technology
Weijia Pharma
Bionna Medicine
Mesochem Technology
SynFarm Pharmaceutical
Abydos Pharma
Dingxintong Pharmaceutical
听
听
*If Applicable.
